(Q30422586)

16 October 2017

7 references

14 March 2019

23 March 2019

21 March 2019

20 July 2020

5 April 2021

15 July 2021

25 October 2022

0 references

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. (English)

1 reference

RNA virus infectious disease

16 October 2017

7 references

14 March 2019

23 March 2019

21 March 2019

1 July 2020

20 July 2020

15 July 2021

25 October 2022

1 reference

1 July 2020

1 reference

20 July 2020

cost-effectiveness analysis

1 reference

1 reference

5 April 2021

1 reference

1

1 reference

16 October 2017

3

1 reference

16 October 2017

10

Anna Noel-Storr

0 references

Andrew Kenneth Burroughs

12

object named as

Andrew K Burroughs

1 reference

16 October 2017

Catriona Crossan

2

1 reference

16 October 2017

Kurinchi Gurusamy

4

1 reference

16 October 2017

Manolo Rodriguez-Peralvarez

5

1 reference

16 October 2017

Konstantinos Mantzoukis

6

1 reference

16 October 2017

Julia O'Brien

7

1 reference

16 October 2017

Evangelos Thalassinos

8

1 reference

16 October 2017

Vassilios Papastergiou

9

1 reference

16 October 2017

Anna Noel-Storr

10

1 reference

16 October 2017

Brian Davidson

11

1 reference

16 October 2017

language of work or name

English

0 references

publication date

29 July 2014

1 reference

16 October 2017

1 September 2014

8 references

14 March 2019

23 March 2019

21 March 2019

1 July 2020

20 July 2020

5 April 2021

15 July 2021

25 October 2022

9 references

16 October 2017

14 March 2019

23 March 2019

21 March 2019

1 July 2020

20 July 2020

5 April 2021

15 July 2021

25 October 2022

60

1 reference

16 October 2017

3

1 reference

16 October 2017

832-843

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

16 October 2017

8 references

14 March 2019

23 March 2019

21 March 2019

1 July 2020

20 July 2020

5 April 2021

15 July 2021

on focus list of Wikimedia project

25 October 2022

ScienceSource

0 references

cites work

Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Is there sufficient evidence to recommend antiviral therapy in hepatitis C?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Sofosbuvir for previously untreated chronic hepatitis C infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Treating viral hepatitis C: efficacy, side effects, and complications

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

EuroQol: the current state of play

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265295

Clinical decisions. Management of incidental hepatitis C virus infection

20 June 2018

1 reference

Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups

21 January 2018

1 reference

Representing uncertainty: the role of cost-effectiveness acceptability curves

21 January 2018

1 reference

Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention

21 January 2018

1 reference

Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice.

21 January 2018

1 reference

Noninvasive assessment of liver fibrosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25043847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/HEP.27296

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

25043847

1 reference